Alcon AG | ALC - Net Income

Stock Price
51.42
Daily Change
1.00 1.98%
Monthly
-17.81%
Yearly
-30.59%
Q2 Forecast
49.42

Alcon AG reported $189M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AstraZeneca USD 3.08B 754M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Essilor EUR 928M 459M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GRIFOLS EUR 73M 25.25M Mar/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Philips EUR 151M 244M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
Smith & Nephew USD 293M 79M Dec/2025
Sonova Holding CHF 188.5M 143.4M Dec/2025
UCB EUR 1.08B 608M Dec/2025